Brillant Trick, that one was right up my alley... I loled But in...

Brillant Trick, that one was right up my alley... I loled

But in all serious Super read the previous posts in this thread.

It refers to the issue at hand for the revelant meeting as advised on the meeting timetable, in the case of TIS it should be consideration of an opinion for approval. Which implies that at the conclusion of the meeting the EMA's CHMP will have made a decison if the product is approved or not.

It basically confirms that within days following the meeting there is going to be a significant revaluing of the stock one way or the other.